WallStreetZenWallStreetZen

NASDAQ: GH
Guardant Health Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

GH past revenue growth

How has GH's revenue growth performed historically?
Company
25.45%
Industry
0.38%
Market
17.61%
GH's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
GH's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
GH's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

GH earnings and revenue history

Current Revenue
$563.9M
Current Earnings
-$479.4M
Current Profit Margin
-85%

GH Return on Equity

Current Company
-301.9%
Current Industry
-24%
Current Market
188%
GH's Return on Equity (-301.9%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when GH announces earnings.

GH Return on Assets

Current Company
-27.7%
Current Industry
6.7%
GH is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

GH Return on Capital Employed

Current Company
-30.13%
Current Industry
11.6%
GH's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

GH vs Diagnostic & Research Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
GH$563.95M-$433.31M-$479.45M+44.14%N/A
NEO$591.64M-$8.37M-$87.97M+16.41%N/A
MYGN$753.20M-$186.10M-$263.30M-1.10%N/A
TWST$262.36M-$169.85M-$205.80M+51.75%N/A
NEOG$929.24M$188.76M$1.57M+17.63%-49.27%
View Top Diagnostic & Research Stocks

GH earnings dates

Next earnings date
May 7, 2024

Guardant Health Earnings & Revenue FAQ

What were GH's earnings last quarter?

On Invalid Date, Guardant Health (NASDAQ: GH) reported Q4 2023 earnings per share (EPS) of -$1.62, up 18.25% year over year. Total Guardant Health earnings for the quarter were -$187.04 million. In the same quarter last year, Guardant Health's earnings per share (EPS) was -$1.37.

If you're new to stock investing, here's how to buy Guardant Health stock.

What was GH's earnings growth in the past year?

As of Q2 2024, Guardant Health's earnings has grown year over year. Guardant Health's earnings in the past year totalled -$479.45 million.

What is GH's earnings date?

Guardant Health's earnings date is Invalid Date. Add GH to your watchlist to be reminded of GH's next earnings announcement.

What was GH's revenue last quarter?

On Invalid Date, Guardant Health (NASDAQ: GH) reported Q4 2023 revenue of $155.05 million up 22.19% year over year. In the same quarter last year, Guardant Health's revenue was $126.89 million.

What was GH's revenue growth in the past year?

As of Q2 2024, Guardant Health's revenue has grown 25.45% year over year. This is 25.07 percentage points higher than the US Diagnostics & Research industry revenue growth rate of 0.38%. Guardant Health's revenue in the past year totalled $563.95 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.